Order Careers Contact Us Sign in Adaptive Biotechnologies Order Careers
Contact Us Sign in Immune Profiling Platform Platform OverviewPublications
Products & Services LIFE SCIENCES RESEARCHimmunoSEQ®CLINICAL
DIAGNOSTICSclonoSEQ®PipelineDRUG DISCOVERYCellular TherapyVaccines
PARTNERSHIPS Cancer Cellular TherapyAntigen MapBiopharma PartnershipsStrategic
Collaborators About Us Our StoryCultureCareersNewsroomContact Us About Us
Newsroom Press News Features Events Contact Media Relations TOP PRESS RELEASES
01/04/2019 Adaptive Biotechnologies to Enter Into Worldwide Collaboration and
License Agreement with Genentech to Develop Personalized Cellular Therapies
for the Treatment of Cancer 01/03/2019 Adaptive Biotechnologies to Present at
the 37th Annual J.P. Morgan Healthcare Conference 09/28/2018 FDA Grants De
Novo Designation for Adaptive Biotechnologies’ clonoSEQ Assay to Detect and
Monitor Minimal Residual Disease (MRD) in Patients with Multiple Myeloma and
Acute Lymphoblastic Leukemia LATEST PRESS RELEASES 08/13/2012 Adaptive Awards
$25,000 to Fund Next Generation of Scientists 07/10/2012 Adaptive CEO Chad
Robins presenting at Life Science Innovation Northwest Conference on July 11
07/07/2012 Adaptive co-founder Harlan Robins, Ph.D., speaking at Next-Gen
Sequencing Applications & Translations Technologies Summit 05/16/2012 New
Study Shows Adaptive Biotechnologies immunoSEQ Assay Significantly More
Sensitive than Traditional Method to Detect Minimal Residual Disease in
Leukemia 03/05/2012 Adaptive Biotechnologies Hires Leading High-Throughput
Sequencing Expert, Dr. Mark Rieder, as Senior Vice President of Operations
01/03/2012 Adaptive TCR changes name to Adaptive Biotechnologies 10/17/2011
Study in the Journal of Immunological Methods confirms accuracy, sensitivity
of Adaptive TCR’s immune profiling technology 09/29/2011 Adaptive TCR Adds
Industry Heavyweights to Board of Directors and Advisory Boards 08/13/2011
Seminal Cancer Study Uses ImmunoSEQ to Validate Results Previous 1 … 13 14 15
Next TOP NEWS FEATURES 01/04/2019 Genentech: A New Age for Neoantigens
01/03/2019 Microsoft Blog: Every immune system has a story to tell; the key is
knowing how to listen 05/09/2018 T Cell Receptor Sequencing IDs Aggressive
Lymphoma Subtype LATEST NEWS FEATURES TOP EVENTS 01/03/2019 J.P. Morgan
Healthcare Conference 2019 12/01/2018 ASH 2018 LATEST EVENTS Contact media
relations phone (917) 912-7195 email media@adaptivebiotech.com
Corporate/Research (855) 466-8667 Diagnostics (888) 522-8988 Immune Profiling
PlatformPlatform Overview Publications Products & ServicesLIFE SCIENCES
RESEARCH immunoSEQ® CLINICAL DIAGNOSTICS clonoSEQ® Pipeline DRUG DISCOVERY
Cellular Therapy Vaccines PartnershipsCancer Cellular Therapy Antigen Map
Biopharma Partnerships Strategic Collaborators About UsOur Story Culture
Careers News & Events Contact Us © Adaptive Biotechnologies. All Rights
Reserved. Terms of Use Online Privacy Policy Privacy Shield Policy HIPAA
Policy Code of Conduct Patents & Trademarks Licenses